ClinicalTrials.gg

How we know

Every link on this study, and who decided it

The study on the left, the conditions and drugs this site links it to, and on each link the judgments that made or checked it, by day and by judge. The top row is the record itself: each new version seen since tracking began. Dashed lines are links the registry record does not make itself. Select a link to see everything judged on it, or a mark for one decision with its reason and evidence.

Why Futibatinib is on this study

  • The record lists it as a treatment.
  • Claude Opus 5.5 judged it tested: part of what the study tests. Nov 3, 2026, 2:43 AM UTC
  • The role rule says the same.
  • So Futibatinib's page lists this study under “Testing it”.
9 links0 made here, not in the record16 judgments2 judges (the rules as one: Rule based)0 record changes seen
Claude Opus 5.5Rule based
Oct 19Oct 26Nov 2Nov 9Nov 16Nov 23TodayNCT07710885Futibatinib (TAS-120) inPatients With AdvancedBiliary Tract CancerTaiho Pharmaceutical Co., Ltd.Phase 3 · recruitingRECORDThe record itselfVersions seen nightly since Sep 25, 2…›No new version seen since tracking began Sep 25, 2026.CONDITIONSBiliary Tract NeoplasmsThe registry's MeSH filing›Nov 14 · Rule based · Finest filed termAs of now · Rule based · Main conditionMain conditionAcrocephalosyndactyliaThe registry's MeSH filing›Nov 14 · Rule based · Finest filed termFinest filed termParkinson Disease 4, Autoso…The registry's MeSH filing›Nov 14 · Rule based · MisfiledMisfiledDRUGSFutibatinibIntervention entry›Nov 3 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedZimberelimabIntervention entry›Nov 3 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedDurvalumabIntervention entry›Nov 3 · Claude Opus 5.5 · ComparatorNov 18 · Rule based · ComparatorComparatorPembrolizumabIntervention entry›Nov 3 · Claude Opus 5.5 · ComparatorNov 18 · Rule based · ComparatorComparatorGemcitabineIntervention entry›Nov 3 · Claude Opus 5.5 · BackgroundNov 18 · Rule based · BackgroundBackgroundCisplatinIntervention entry›Nov 3 · Claude Opus 5.5 · BackgroundNov 18 · Rule based · BackgroundBackground

Times are in your time zone; a day marked “day only” kept no time. The graph scrolls sideways on a narrow screen; every mark is also in the list below.

All judgments on this study

WhenLinkJudgeDecisionState
Nov 3FutibatinibClaude Opus 5.5TestedCurrent
Nov 3ZimberelimabClaude Opus 5.5TestedCurrent
Nov 3DurvalumabClaude Opus 5.5ComparatorCurrent
Nov 3PembrolizumabClaude Opus 5.5ComparatorCurrent
Nov 3GemcitabineClaude Opus 5.5BackgroundCurrent
Nov 3CisplatinClaude Opus 5.5BackgroundCurrent
Nov 14Biliary Tract NeoplasmsRule based · condition-kind ruleFinest filed termCurrent
Nov 14AcrocephalosyndactyliaRule based · condition-kind ruleFinest filed termCurrent
Nov 14Parkinson Disease 4, Autosomal Dominant Lewy BodyRule based · condition-kind ruleMisfiledCurrent
Nov 18FutibatinibRule based · role ruleTestedAgrees
Nov 18ZimberelimabRule based · role ruleTestedAgrees
Nov 18DurvalumabRule based · role ruleComparatorAgrees
Nov 18PembrolizumabRule based · role ruleComparatorAgrees
Nov 18GemcitabineRule based · role ruleBackgroundAgrees
Nov 18CisplatinRule based · role ruleBackgroundAgrees
As of nowBiliary Tract NeoplasmsRule based · main-condition ruleMain conditionCurrent

The rules, in plain words

“Rule based” means one of these decided, not a model or a person. Each runs every night over every study.

Which drugs a study tests

Reads each treatment the study lists and the arms it is in. A drug only in the experimental arm is tested. A drug in every arm while something else changes between the arms is given beside it. A drug only in the control arm is the comparator. Placebo, procedures and usual care are known by name.

Where the whole record has been read, that reading's answer replaces the rule's.

What a study is mainly about

Starts from the first condition ClinicalTrials.gov files the study under. It moves to a narrower one only when the study's own title or listed conditions name it, and sets aside terms the registry often files by mistake. A study open to many cancers is not placed under one of them unless its title names it.

Checked against studies judged one by one; the study page says when it differs from the registry.

How a condition link is counted

For each condition a study is filed under: whether it is the study's own condition at the finest the study states it, a wider one, a general category, or filed by mistake; and whether it is the main condition, a setting the study names, or only how it was filed.

A decision on file for one study overrides it, with who made it and when.